Why It Matters

The House Small Business Committee’s November 20 hearing represents a crucial test of bipartisan manufacturing ambitions, with federal policy’s ability to revitalize domestic production and create Main Street jobs at stake.

For small businesses: Access to capital and competitive parity with imports are existential issues. The Investing in All of America Act seeks to unlock SBIC funding for manufacturers, addressing a key bottleneck. Without clarity on tariffs, subsidies, and workforce policy, investment commitments remain uncertain.

For local economies: Rep. Van Duyne’s district alone contains 21,000 manufacturing workers and 537 manufacturing businesses, with manufacturing jobs directly translating to community economic health. Chairman Williams championed a 25% truck tariff to protect Peterbilt jobs in North Texas, illustrating the link between trade policy and regional employment.

For supply chain security: Pharmaceutical, automotive, and defense sectors are actively lobbying for domestic production. FujiFilm, EMD Millipore, and American Laboratories Pharma are pushing for biosecure manufacturing capacity built in the U.S.

The central tension: While Rep. Meuser’s bipartisan bill passed committee unanimously, the hearing must address concrete obstacles around funding, agency coordination, and sustaining momentum amid competing fiscal priorities.

Broader Context

Congress is pushing hard to revitalize domestic manufacturing amid growing concerns over foreign economic dependency and supply chain fragility. Rep. Mark Alford (R-MO-4) has explicitly called for onshoring chip, pharmaceutical, and other sectors to reduce reliance on China.

The manufacturing renaissance narrative centers on three key drivers:

The Agenda

The November 20 hearing will feature testimony from small business owners and industry experts on domestic manufacturing revitalization across critical sectors.

Key witness categories likely to participate:

Between The Lines

Committee Chair Roger Williams (R-TX-25) is leading the domestic manufacturing revival charge. He’s used media platforms to amplify his message, telling Newsmax his small business bill will "Open Up Main Street America."

Rep. Daniel Meuser (R-PA-9) introduced the bipartisan Investing in All of America Act, which unlocks capital for small manufacturers by amending Small Business Investment Company leverage caps.

Rep. Beth Van Duyne (R-TX-24) represents a manufacturing powerhouse with 21,000 manufacturing workers and 537 manufacturing businesses in her district. She’s actively engaged with the SBA’s Made in America Manufacturing Initiative.

Rep. Hillary J. Scholten (D-MI-3) secured $4.9 million in federal funding for Michigan’s Manufacturing Extension Partnership Program and conducted site visits to manufacturers like Automatic Spring Manufacturing.

Competitive Landscape

Multiple industries are actively lobbying on domestic manufacturing issues. California Life Sciences has spent hundreds of thousands advocating for "robust domestic supply chain development." The pharmaceutical sector is heavily engaged, with American Laboratories Pharma LLC lobbying on "Manufacturing Domestic Supply Reforms."

Automotive companies are key players. Scout Motors Inc. engaged in sustained 2025 lobbying on domestic manufacturing tax incentives, while Lucid USA Inc. advocates for domestic manufacturing support.

The Bottom Line

The November 20 hearing reflects genuine bipartisan momentum behind domestic manufacturing revival. Congressional members are advancing legislation like the Investing in All of America Act, while companies across sectors lobby for onshoring policies. However, translating policy support into sustained manufacturing growth hinges on resolving practical obstacles around capital access, workforce development, and regulatory clarity that the committee has yet to directly address.

For more detailed insights access Legis1. Request a demo today!

Spot something wrong? Report an issue with this article